<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="340">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 18, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753346</url>
  </required_header>
  <id_info>
    <org_study_id>I11-670-20</org_study_id>
    <nct_id>NCT04753346</nct_id>
  </id_info>
  <brief_title>Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19</brief_title>
  <official_title>Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19 and Investigation of Factors Affecting Physical Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      COVID-19 (Coronavirus disease 2019) is a new infectious disease caused by a virus named as&#xD;
      SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2). Although it can have a&#xD;
      devastating effect on many organs, the respiratory tract is particularly affected. In the&#xD;
      course of the disease, a wide clinical spectrum is observed, from flu-like illness to lung&#xD;
      failure. Some of the patients who survived the disease continue to have problems such as&#xD;
      shortness of breath, fatigue, decrease in walking distance, decrease in participation in&#xD;
      daily life activities. These problems suggest that the effects on respiratory and cardiac&#xD;
      functions continue even after the disease ends. This study was designed to demonstrate the&#xD;
      effects and extent of COVID-19 on cardiopulmonary capacity.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aims of the research are that demonstrate change in cardiopulmonary fitness level in patients&#xD;
      with COVID-19 according to normal values and reveal the relationship of this change with age,&#xD;
      gender, physical activity level, disease severity and accompanying medical conditions.&#xD;
&#xD;
      Patients older than 18 years old who are diagnosed with COVID-19 according to clinical&#xD;
      symptoms and rt-PCR test positivity and at least 30 days past the end of their symptoms are&#xD;
      accepted for the study.&#xD;
&#xD;
      According to World Health Organization's (WHO) classification, COVID-19 disease severity is&#xD;
      determined. Physical activity level of the patients before COVID-19 is evaluated with&#xD;
      International Physical Activity Questionnaire. Risk of anxiety and depression of the patients&#xD;
      is identified with Hospital Anxiety and Depression Scale (HADS), which has 14 questions. To&#xD;
      evaluate cardiopulmonary fitness level, cardiopulmonary exercise test (CPET) and 6-minute&#xD;
      walk test are applied. Cardiopulmonary exercise test is gold standard to determine cardiac&#xD;
      and respiratory functions. Pulmonary function test is performed to identify the conditions&#xD;
      that affect the results of cardiopulmonary exercise test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 15, 2021</start_date>
  <completion_date type="Anticipated">January 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peak oxygen uptake</measure>
    <time_frame>1-6 months</time_frame>
    <description>Cardiopulmonary exercise test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen uptake at anaerobic threshold</measure>
    <time_frame>1-6 months</time_frame>
    <description>Cardiopulmonary exercise test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Borg rating of perceived exertion scale</measure>
    <time_frame>1-6 months</time_frame>
    <description>Cardiopulmonary exercise test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Walk distance</measure>
    <time_frame>1-6 months</time_frame>
    <description>6 minute walk test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Borg dyspnea scale</measure>
    <time_frame>1-6 months</time_frame>
    <description>Cardiopulmonary exercise test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety score</measure>
    <time_frame>1-6 months</time_frame>
    <description>Hospital Anxiety and Depression Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression score</measure>
    <time_frame>1-6 months</time_frame>
    <description>Hospital Anxiety and Depression Scale</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>COVID 19</condition>
  <arm_group>
    <arm_group_label>Mild Disease</arm_group_label>
    <description>Symptomatic patients meeting the case definition for COVID-19 without evidence of viral pneumonia or hypoxia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pneumonia</arm_group_label>
    <description>Patients with clinical signs of pneumonia (fever, cough, dyspnoea, fast breathing) but no signs of severe pneumonia, including SpO2 ≥ 90% on room air</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Severe Pneumonia</arm_group_label>
    <description>Patients with clinical signs of pneumonia (fever, cough, dyspnoea,fast breathing) plus one of the following: respiratory rate &gt; 30 breaths/min; severe respiratory distress; or SpO2 &lt; 90% on room air.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Critical Disease</arm_group_label>
    <description>Patients have one of the following: acute respiratory distress syndrome; sepsis; or septic shock.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical Activity Level</intervention_name>
    <description>International Physical Activity Questionnaire</description>
    <arm_group_label>Critical Disease</arm_group_label>
    <arm_group_label>Mild Disease</arm_group_label>
    <arm_group_label>Pneumonia</arm_group_label>
    <arm_group_label>Severe Pneumonia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Anxiety and Depression Assessment</intervention_name>
    <description>Hospital Anxiety and Depression Scale</description>
    <arm_group_label>Critical Disease</arm_group_label>
    <arm_group_label>Mild Disease</arm_group_label>
    <arm_group_label>Pneumonia</arm_group_label>
    <arm_group_label>Severe Pneumonia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Exercise Capacity</intervention_name>
    <description>6 Minute Walk Test</description>
    <arm_group_label>Critical Disease</arm_group_label>
    <arm_group_label>Mild Disease</arm_group_label>
    <arm_group_label>Pneumonia</arm_group_label>
    <arm_group_label>Severe Pneumonia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pulmonary Function Test</intervention_name>
    <description>Spirometry</description>
    <arm_group_label>Critical Disease</arm_group_label>
    <arm_group_label>Mild Disease</arm_group_label>
    <arm_group_label>Pneumonia</arm_group_label>
    <arm_group_label>Severe Pneumonia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiopulmonary Fitness Level</intervention_name>
    <description>Cardiopulmonary Exercise Test</description>
    <arm_group_label>Critical Disease</arm_group_label>
    <arm_group_label>Mild Disease</arm_group_label>
    <arm_group_label>Pneumonia</arm_group_label>
    <arm_group_label>Severe Pneumonia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients applying to COVID-19 follow-up clinics&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of SARS-Cov2 with a positive result of reverse polymerase-transcriptase&#xD;
             chain reaction test&#xD;
&#xD;
          -  It must have been at least 30 days after symptoms of COVID-19 improved.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  5 days after acute myocardial infarction&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Active endocarditis, myocarditis or pericarditis&#xD;
&#xD;
          -  Symptomatic severe aortic stenosis&#xD;
&#xD;
          -  Uncontrolled heart failure&#xD;
&#xD;
          -  Acute pulmonary embolus, pulmonary infarction or thrombosis of lower extremities&#xD;
&#xD;
          -  Suspected dissecting aneurysm&#xD;
&#xD;
          -  Uncontrolled asthma&#xD;
&#xD;
          -  Room air desaturation at rest (O2 ⩽85%)&#xD;
&#xD;
          -  Respiratory failure&#xD;
&#xD;
          -  Acute non-cardiopulmonary disorder that may affect exercise performance or be&#xD;
             aggravated by exercise&#xD;
&#xD;
          -  Mental impairment&#xD;
&#xD;
          -  Severe untreated arterial hypertension at rest (&gt;200 mm Hg systolic, &gt;120 mm Hg&#xD;
             diastolic)&#xD;
&#xD;
          -  High-degree atrioventricular block&#xD;
&#xD;
          -  Orthopaedic, neurological or systemic impairments that leading to inability to perform&#xD;
             test&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Burak K Turan</last_name>
    <phone>90(312)5082822</phone>
    <email>burakkamilturan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yesim Aytür</last_name>
    <phone>90(312)5082822</phone>
    <email>kurtais@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ankara University, Faculty of Medicine, Physical Medicine and Rehabilitation Department</name>
      <address>
        <city>Ankara</city>
        <zip>06230</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Burak K Turan</last_name>
      <phone>90(312)5082822</phone>
      <email>burakkamilturan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2021</study_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>Burak Kamil Turan</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Cardiopulmonary exercise test</keyword>
  <keyword>Exercise capacity</keyword>
  <keyword>COVID 19</keyword>
  <keyword>6 minute walk test</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

